Moving off the critical path: Streamlining strategies for drug substance synthesis and manufacturing
Pharmaceutical Technology
JUNE 26, 2022
Placing traditionally siloed drug substance and drug product development activities within a single organization that also has commercial manufacturing capabilities accelerates clinical development and builds in quality and robustness of supply. Integrated drug substance and drug product services. Polymorphic form issues.
Let's personalize your content